Published • loading... • Updated
Roche, Eli Lilly’s Alzheimer’s blood test gets U.S. FDA clearance
The test is intended for adults 55 and older with cognitive decline and is meant to improve access to less invasive Alzheimer’s evaluation.
- On Monday, the U.S. Food and Drug Administration cleared the Elecsys pTau217 blood test from Roche and Eli Lilly to identify Alzheimer's-related brain changes in adults aged 55 and older with cognitive decline.
- Previously, doctors relied on expensive, invasive PET scans or cerebrospinal fluid testing to detect Alzheimer's pathology, creating barriers for patients seeking early diagnosis of cognitive decline.
- Roche and Lilly stated the test is "minimally invasive" and operates alongside "existing laboratory workflows," meaning clinics will not need to purchase additional equipment.
- Both Labcorp and Quest Diagnostics plan to offer the test through their laboratory networks, potentially expanding access across the United States later this year.
- Early diagnosis allows patients to begin treatments when they are most effective, positioning this clearance within a broader landscape of Alzheimer's tests including C2N Diagnostics' PrecivityAD2 for adults as young as 40.
Insights by Ground AI
13 Articles
13 Articles
(Las Vegas = Yonhap News) Correspondent Kim Kyung-yoon = It is expected that Alzheimer's disease will be accurately diagnosed at local clinics through a simple blood test.
·Seoul, Korea (the Republic of)
Read Full Article
The Food and Drug Administration of the United States (FDA) approved a blood test to identify symptoms of Alzheimer's disease, developed jointly by Roche and Eli Lilly. Exclusive material for subscribers. To have full access, access the link of the material and register.
·Rio de Janeiro, Brazil
Read Full Article
For the first time, new blood test can help detect Alzheimer’s from age 40
A new FDA-approved blood test could help detect Alzheimer’s from age 40 by measuring proteins linked to brain amyloid; intended for people with cognitive decline, it showed high predictive accuracy and is due in the US later this year
·Tel Aviv-Yafo, Israel
Read Full ArticleCoverage Details
Total News Sources13
Leaning Left2Leaning Right3Center6Last UpdatedBias Distribution55% Center
Bias Distribution
- 55% of the sources are Center
55% Center
L 18%
C 55%
R 27%
Factuality
To view factuality data please Upgrade to Premium
